- Home
- CRWD vs ABT Comparison
CRWD vs ABT Comparison
Compare CRWD & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRWD | ABT |
|---|---|---|
| Founded | 2011 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.5B | 152.9B |
| IPO Year | 2019 | 2006 |
Fundamental Metrics
Financial Performance| Metric | CRWD | ABT |
|---|---|---|
| Price | $659.58 | $90.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 48 | 20 |
| Target Price | ★ $507.00 | $130.90 |
| AVG Volume (30 Days) | 3.5M | ★ 9.5M |
| Earning Date | 06-02-2026 | 04-16-2026 |
| Dividend Yield | N/A | ★ 2.76% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.11 | ★ 0.61 |
| Revenue | $4,812,005,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $24.85 | $10.75 |
| Revenue Next Year | $21.40 | $8.10 |
| P/E Ratio | $6,152.73 | ★ $149.32 |
| Revenue Growth | ★ 21.71 | 5.67 |
| 52 Week Low | $342.72 | $81.97 |
| 52 Week High | $785.66 | $137.49 |
Technical Indicators
Market Signals| Indicator | CRWD | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 55.09 | 55.02 |
| Support Level | $477.12 | $84.96 |
| Resistance Level | $785.66 | $129.65 |
| Average True Range (ATR) | 33.96 | 1.68 |
| MACD | -6.10 | 0.99 |
| Stochastic Oscillator | 23.70 | 72.07 |
Price Performance
Historical ComparisonAbout CRWD CrowdStrike Holdings Inc.
CrowdStrike is a cloud-native cybersecurity company specializing in security verticals such as endpoint, cloud workload, identity, and security operations. CrowdStrike's primary offering is its Falcon platform, which provides enterprises with a unified view to detect and respond to security threats across their IT infrastructure. The Austin, Texas-based firm was founded in 2011 and went public in 2019.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.